(Press-News.org) In cases of mild congenital heart defects, more prenatal visits are associated with greater likelihood of appropriate delivery at a community hospital, according to a study published in JAMA Network Open. Results suggest that more prenatal care is beneficial for families and may allow their newborns with mild heart defects to receive the right level of care closer to home, as opposed to traveling to a regional cardiac surgical center, which can be expensive, taxing and stressful for families.
Congenital heart defects are the most common and resource-intensive birth defects in the United States. Infants with the most complex heart defects are usually directed to regional cardiac surgical centers, while babies with mild heart defects can safely receive the right care at a community hospital.
“Our findings underscore the importance of prenatal care in driving the utilization of appropriate care for newborns with heart defects,” said senior author Joyce Woo, MD, MS, pediatric cardiologist at Ann & Robert H. Lurie Children’s Hospital of Chicago and Assistant Professor of Pediatrics and Medical Social Sciences at Northwestern University Feinberg School of Medicine. “One prenatal visit is usually not enough, since fetal heart disease can change over the duration of pregnancy. It can potentially become less severe than initially suspected. If the newborn does not need surgery right away, then remaining closer to home for delivery can be the right decision. Many families might prefer that. Risk-appropriate care benefits the overall healthcare system too.”
In the study, Dr. Woo and colleagues used a statewide administrative database to analyze data on 12,113 babies born with heart defects in Illinois between 2013-2021. They aimed to estimate how two components of prenatal care adequacy – initiation of care and frequency of visits – are related to delivery location for neonates with congenital heart defects.
They found that delayed prenatal care initiation was associated with increased likelihood of delivery at a cardiac surgical center compared to no prenatal care, regardless of the severity of the heart defect. But for babies with mild congenital heart defects, more prenatal visits were associated with a 7 percentage-point decrease in probability of delivery at a cardiac surgical center.
“Caring for children with heart defects begins before birth. Prenatal care ensures that babies with congenital heart defects are born at the right location with the appropriate intensity of care based on their clinical needs. It also allows for consideration for their family’s preferences for delivery location,” said Dr. Woo. “Our findings can also help inform statewide policies on perinatal resource allocation.”
This analysis will be presented at the American Heart Association Scientific Sessions on November 9, 2025.
Dr. Woo receives salary support from the National Institutes of Health (NIH/NHLBI K01HL171819).
Ann & Robert H. Lurie Children’s Hospital of Chicago is a nonprofit organization committed to providing access to exceptional care for every child. It is the only independent, research-driven children’s hospital in Illinois and one of less than 35 nationally. This is where the top doctors go to train, practice pediatric medicine, teach, advocate, research and stay up to date on the latest treatments. Exclusively focused on children, all Lurie Children’s resources are devoted to serving their needs. Research at Lurie Children’s is conducted through Stanley Manne Children’s Research Institute, which is focused on improving child health, transforming pediatric medicine and ensuring healthier futures through the relentless pursuit of knowledge. Lurie Children’s is the pediatric training ground for Northwestern University Feinberg School of Medicine. It is ranked as one of the nation’s top children’s hospitals by U.S. News & World Report.
END
More prenatal visits linked to right level of care for infants born with heart defects
More prenatal visits provide families the reassurance that their baby with a mild heart defect will receive appropriate care
2025-11-09
ELSE PRESS RELEASES FROM THIS DATE:
Drink Up: Coffee is safe for people with A-Fib
2025-11-09
Drinking coffee can protect against atrial fibrillation (A-Fib), a common heart rhythm disorder that causes rapid, irregular heartbeat and can lead to stroke and heart failure.
Doctors typically recommend that people with heart issues like A-Fib avoid caffeine out of fear that it will trigger symptoms. But a study by UC San Francisco and the University of Adelaid has concluded that drinking a cup of caffeinated coffee a day reduced A-Fib by 39%.
“Coffee increases physical activity which is known to reduce atrial fibrillation,” said Gregory M. Marcus, MD, MAS, ...
Study reports on global trends in acute kidney injury– related mortality
2025-11-08
Houston, TX (November 8, 2025) — A 5-year study revealed a stability of globalacute kidney injury (AKI)–related mortality rates with differing patterns that indicate a rising concentration of mortality in older populations and higher socioeconomiccountries. The findings will be presented at ASN Kidney Week 2025 November 5– 9.
When investigators at the Kyung Hee University Hospital in Seoul assessed AKI-related mortality trends in 43 countries from 1996–2021 using the WHO MortalityDatabase, they ...
Study reveals a potentially better way to optimize the timing for kidney transplant waitlisting
2025-11-08
Houston, TX (November 8, 2025) — The current kidney transplant waitlistingcriterion is based on a single measurement of kidney function (estimated glomerular filtration rate [eGFR] ≤20 ml/min/1.73m2) and does not consider an individual’s risk of progressing to kidney failure. A new study reveals that inclusion of a patient’s 2-year risk of progression to kidney failure (using theKidney Failure Risk Equation [KFRE], which incorporates age, ...
Transitional dialysis program in Texas decreased the use of emergency dialysis
2025-11-08
Houston, TX (November 8, 2025) — The cost of emergency dialysis is estimated to be 8-times that of in-center dialysis. A new study reveals that a transitional dialysis program piloted in Travis County (Austin, TX) resulted in a significant decrease in emergency department visits and hospital admissions for emergency dialysis by providing a pathway for outpatient dialysis in uninsured patients. Thefindings will be presented at ASN Kidney Week 2025 November 5– ...
Quality improvement intervention may help prevent deaths from metformin-associated lactic acid
2025-11-08
Houston, TX (November 8, 2025) — Metformin-associated lactic acidosis(MALA) is a rare but serious adverse effect of the diabetes drug metformin in which the body accumulates too much lactic acid. Investigators developed and tested a protocol for diagnosis and treatment of MALA. Their work will be presented at ASN Kidney Week 2025 November 5– 9.
The protocol, which included immediate initiation of dialysis using either intermittent hemodialysis, continuous kidney replacement therapy, or peritonealdialysis as treatment, ...
Conservative care versus dialysis: model indicates which is best for individual patients with advanced chronic kidney disease
2025-11-08
Houston, TX (November 8, 2025) — It can be challenging to identify which patients with advanced chronic kidney disease (CKD) will most benefit from conservative care rather than initiating dialysis. Researchers recently developed and validated a prediction model to estimate individualized survival probabilities with conservative non-dialytic management versus dialysis in patients with advanced CKD from the national Veterans Affairs and OptumLabs® DataWarehouse databases. The work will be presented at ASN Kidney Week 2025 November 5–9.
Investigators found that among veterans with advanced CKD who received dialyticversus ...
Coronary artery calcium may be a predictor for all-cause mortality, including medical conditions not related to heart health
2025-11-08
In a new study of more than 40,000 patients, researchers at Intermountain Health in Salt Lake City have found that patients who have no evidence of calcium in their coronary arteries are not only significantly less likely to die from heart conditions – including heart attacks and heart failure– but also are at reduced risk of death from non-cardiac medical conditions.
Coronary artery calcium (CAC) is a strong predictor of how likely someone is to develop clinical coronary artery disease. It is an excellent measure of coronary plaque burden.
When cholesterol-laden plaque builds up in the coronary arteries, blood flow to heart muscle is limited, and plaque rupture with coronary ...
Minimally invasive coronary calcium CT scans used to determine heart disease risk are effective at finding other potential health problems
2025-11-08
Coronary artery calcium (CAC) CT scans are becoming a more commonly used tool to effectively determine a patient’s future risk of heart disease and heart attack.
These minimally invasive scans measure how much calcium is already present in the arteries of the heart, so that clinicians can determine if a patient needs medical intervention or other preventative measures, including statin medications.
Now an important new study from heart researchers at Intermountain Health in Salt Lake City ...
High-impact clinical trials generate promising results for improving kidney health - part 3
2025-11-08
Sodium-glucose co-transporter 2 (SGLT2) inhibitors reduce albuminuria (excess albumin in the urine) and the risk of chronic kidney disease (CKD) progression, and certain mineralocorticoid receptor antagonists have similar effects in people with type 2 diabetes and CKD. Investigators recently assessed the albuminuria-lowering efficacy and safety of the novel mineralocorticoid receptor antagonist balcinrenone combined with the SGLT2 dapagliflozin. In the double-blind, active-controlled clinical trial, both doses of this novel balcinrenone/dapagliflozin combination outperformed dapagliflozin alone, cutting levels of ...
Mass General Brigham researchers find PCSK9 inhibitor reduced risk of first heart attack, stroke
2025-11-08
Researchers from Mass General Brigham have unveiled the results of a large clinical trial that found that adding the drug evolocumab to patients’ treatment significantly reduced the risk of major adverse cardiovascular events in those who are at high risk. Results were presented today at the American Heart Association Scientific Sessions and simultaneously published in The New England Journal of Medicine.
“The results of this trial offer hope for preventing a first heart attack, stroke, or other ...
LAST 30 PRESS RELEASES:
Major international study confirms that beta-blockers are no longer needed in post-infarction patients with normal heart function
Targeted vitamin D3 supplementation cuts risk of heart attack patients having a second heart attack in half, new intermountain health study finds
Any form of hypertension during pregnancy significantly increases postpartum cardiovascular risk including death, new study finds
Opening all blocked arteries with stents reduces risk of death from cardiovascular causes compared with opening only the culprit artery in heart attack patients
More prenatal visits linked to right level of care for infants born with heart defects
Drink Up: Coffee is safe for people with A-Fib
Study reports on global trends in acute kidney injury– related mortality
Study reveals a potentially better way to optimize the timing for kidney transplant waitlisting
Transitional dialysis program in Texas decreased the use of emergency dialysis
Quality improvement intervention may help prevent deaths from metformin-associated lactic acid
Conservative care versus dialysis: model indicates which is best for individual patients with advanced chronic kidney disease
Coronary artery calcium may be a predictor for all-cause mortality, including medical conditions not related to heart health
Minimally invasive coronary calcium CT scans used to determine heart disease risk are effective at finding other potential health problems
High-impact clinical trials generate promising results for improving kidney health - part 3
Mass General Brigham researchers find PCSK9 inhibitor reduced risk of first heart attack, stroke
Triglyceride-lowering drug significantly reduced rate of acute pancreatitis in high-risk patients
Steatotic liver disease and cancer: From pathogenesis to therapeutic frontiers
SGLT2 inhibitors and kidney outcomes by glomerular filtration rate and albuminuria
Comprehensive analysis supports routine use of metabolic drug for people with all levels of kidney function
Temporary benefit for immune system in early HIV treatment, but dysregulation returns
Chronic kidney disease is now the ninth leading cause of death
Chronic kidney disease has more than doubled since 1990, now affecting nearly 800 million people worldwide
Participant experiences in a kidney failure care intervention in the navigate-kidney study
Community health worker support for Hispanic and Latino individuals receiving hemodialysis
Scientists unveil new strategies to balance farming and ecological protection in Northeast China
UT Health San Antonio scientist helps shape new traumatic brain injury guidelines
Rising nitrogen and rainfall could supercharge greenhouse gas emissions from the world’s largest grasslands
Study uncovers glomerular disease outcomes across the lifespan
Sotagliflozin outperforms dapagliflozin for reducing salt- sensitive hypertension and kidney injury in rats
Trial analysis reveals almost all adults with hypertensive chronic kidney disease would benefit from intensive blood pressure lowering
[Press-News.org] More prenatal visits linked to right level of care for infants born with heart defectsMore prenatal visits provide families the reassurance that their baby with a mild heart defect will receive appropriate care